gr 117289 has been researched along with Goldblatt Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drew, GM; Gardner, CJ; Hilditch, A; Hunt, AA; Middlemiss, D; Polley, J; Robertson, MJ; Ross, BC; Travers, A; Twissell, DJ | 1 |
1 other study(ies) available for gr 117289 and Goldblatt Syndrome
Article | Year |
---|---|
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Callithrix; Dogs; Dose-Response Relationship, Drug; Hypertension; Hypertension, Renovascular; Injections, Intra-Arterial; Male; Nicotinic Acids; Rats; Rats, Inbred SHR; Tetrazoles | 1994 |